It is about the drug Kymriah, writes Oxford Biomedica.
See also: Why cancer becomes incurable: explanations of scientists
On the production of the drug filed a branch of a major Swiss pharmaceutical manufacturer Novartis. These drugs will be the first drug in the country to use CAR-T-cell therapy.
The treatment itself begins with the selection of cells from the patient’s immune system.
These T cells are genetically "reprogrammed." After that, these cells return to the patient’s body and destroy the cancer cells with their own resources.
Drugs are prescribed to treat leukemia and other types of blood cancer, from which there is no therapy so far.
For more news on treatment, medicine, nutrition, healthy lifestyles, and more, see the Health section.